Alterity Therapeutics (ATHE) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Alterity Therapeutics

· ATHE

Dashboard

Financials

Ratios

Valuation

Statistics

56.281 M

-6.99%

Alterity Therapeutics (ATHE) Company Statistics | The Fly

General

Market Cap: $60.51M
Enterprise Value: $43.35M
Shares Outstanding: 217,690,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -50.85%
ROE: -48.25%
ROIC: -57.61%
Current Ratio: 14.52
Debt-to-Equity: 0.00
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.23
P/S: —
P/FCF: —
P/B: —
EV/EBITDA: -1.53

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $19.65M
Operating Income: -$19.73M
Net Profit: -$16.27M

Balance Sheet

Cash and Equivalents: $25.93M
Working Capital: $29.65M
Total Assets: $31.98M
Net Debt: -$25.8M
Total Liabilities: $2.29M
Total Equity: $29.69M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$16.14M
Cash Flow from Investing: $5.47M
Cash Flow from Financing: $13.96M
Free Cash Flow: —
Capital Expenditures: —